73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Montag, 30.05.2022
Gliome – Molekulare Marker/Gliomas – Molecular markers
Meeting Abstract
(V001)
[Full Text]
Expression level of Ubiquitin C-terminal hydrolase L1 in tumours of the central nervous system correlates with the amount of present neurons
Kuhl S, Goldbrunner R, Timmer M[Full Text]
Meeting Abstract
(V002)
[Full Text]
Protoporphyrin IX in serum of glioblastoma patients after 5-ALA administration – a potential biomarker?
Walke A, Krone C, Hellwig S, Müther M, Stummer W, König S, Suero-Molina E[Full Text]
Meeting Abstract
(V003)
[Full Text]
Challenge and clinical relevance of a non-matching classifier output in genome-wide DNA methylation analysis for CNS neoplasms
Drexler R, Westphal M, Schüller U, Mohme M[Full Text]
Meeting Abstract
(V004)
[Full Text]
Impact of GAP-43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas
Krigers A, Demetz M, Moser P, Kerschbaumer J, Brawanski K, Thomé C, Freyschlag CF[Full Text]
Meeting Abstract
(V005)
[Full Text]
DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients
Drexler R, Ricklefs FL, Wollmann K, Eckhardt A, Heiland DH, Sauvigny T, Schüller U, Dührsen L[Full Text]
Meeting Abstract
(V006)
[Full Text]
Deciphering the methylation signature of circulating extracellular vesicle DNA for CNS tumour classification
Ricklefs FL, Ricklefs T, Maire C, Salviano da Silva A, Wollmann K, Sauvigny T, Dührsen L, Schüller U, Westphal M, Lamszus K[Full Text]
